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RESEARCH
Verotoxigenic Escherichia coli infections in humans cause 
disease ranging from uncomplicated intestinal illnesses to 
bloody diarrhea and systemic sequelae, such as hemolytic 
uremic syndrome (HUS). Previous research indicated that 
pigeons may be a reservoir for a population of verotoxigenic 
E. coli producing the VT2f variant. We used whole-genome 
sequencing to characterize a set of VT2f-producing E. coli 
strains from human patients with diarrhea or HUS and from 
healthy pigeons. We describe a phage conveying the vtx2f 
genes and provide evidence that the strains causing milder 
diarrheal disease may be transmitted to humans from pi-
geons. The strains causing HUS could derive from VT2f 
phage acquisition by E. coli strains with a virulence genes 
asset resembling that of typical HUS-associated verotoxi-
genic E. coli.
Verotoxigenic Escherichia coli (VTEC) infections in hu-mans cause a wide spectrum of clinical manifestations 
ranging from uncomplicated forms of intestinal illnesses to 
bloody diarrhea and systemic sequelae, such as hemolytic 
uremic syndrome (HUS) (1). The most severe forms are 
caused by the damage inflicted by the verocytotoxins (VTs) 
to the target cells in the intestinal mucosa and the renal 
blood vessels (1). The genes encoding the verocytotoxins 
(vtx) are harbored by lambdoid bacteriophages, which can 
be transferred to multiple bacterial hosts, generating a great 
diversity in the bacterial types that produce such toxins (2).
The most well-known VTEC serogroup, O157, inhab-
its the gastrointestinal tract of ruminants, especially cattle. 
However, this and other VTEC serotypes have been isolated 
from the feces of several other animal species, including 
deer, pigs, horses, cats, dogs, and wild birds (3).
During a program aimed at the control of the pigeon 
population in Rome, Italy during 1998, G. Dell’Omo et al. 
observed that this animal species was a carrier of VTEC 
(4). In that study, VTEC of multiple serogroups were iso-
lated from ≈10% of the animals tested. Of 16 VTEC, 15 
carried the eae gene encoding the intimin and featured 
genetic determinants that produced a subtype of verocyto-
toxin type 2 not described before, later designated VT2f 
(4–6). The finding of such a high prevalence of VTEC in 
pigeons living in Rome led to further research into these 
bacteria in this and other bird species worldwide. Almost 
all these studies succeeded in isolating VTEC, with preva-
lence ranging 3% to >19% in different countries and bird 
species; most VTEC isolated from pigeon feces and cloa-
cal swab samples harbored the genes encoding the VT2f 
subtype (7–10). These findings emphasize the existence of 
a strict association between VTEC carrying the vtx2f genes 
and pigeons, which represent a reservoir for such strains.
Data on human illness attributable to VT2f-producing 
E. coli has been scarce until recent reports from Germany 
and the Netherlands described the isolation of such strains 
from diarrheal stool specimens from humans (11,12). Fur-
thermore, in the Netherlands, an HUS case was recently 
reported to be associated with the presence of a VT2f-
producing O8:H19 strain (13). We aimed to characterize 
at the whole-genome level 3 E. coli strains that produced 
the VT2f isolated from HUS and to investigate their rela-
tionships with VT2f-producing E. coli isolated from human 
diarrheal cases and from the pigeon reservoir.
Materials and Methods
Bacterial Strains
We investigated 22 Vt2f -producing E. coli strains. Eight 
previously described strains were isolated from pigeons in 
Italy (4); eleven strains were isolated in the Netherlands 
from fecal specimens from humans with diarrhea during 
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2008–2012 and are part of the collections held at the Na-
tional Institute for Public Health and the Environment in 
the Netherlands (RIVM) (12). Of the 3 VT2f-producing E. 
coli from HUS patients, 1 was isolated in Austria in 2013 
and 2 in Italy during 2013–2014. A total of 23 unrelated 
VTEC non-O157 strains that produced VT1 and/or VT2 
subtypes other than VT2f have been used for the com-
parison of the profiles of virulence genes with those of the 
VT2f-producing isolates (Table 1).
Whole-Genome Sequencing of E. coli Strains
Sequencing of the strains isolated from fecal samples from 
humans with diarrhea and from pigeons was outsourced 
to the Central Veterinary Institute, Wageningen Uni-
versity (Lelystad, the Netherlands). Genome sequences 
were obtained by using a TruSeq protocol on an Illumina 
MiSeq PE300 platform (Illumina, San Diego, CA, USA). 
The genomes of the 3 VT2f-producing isolates from 
HUS patients were sequenced by using an Ion Torrent 
PGM (Thermo Fisher Scientific, Waltham, MA, USA) 
according to 400-bp protocols for library preparation 
through enzymatic shearing, Ion OneTouch2 emulsion 
PCR, enrichment, and Hi-Q sequencing kits (Thermo 
Fisher Scientific).
The whole-genome sequences (WGSs) of the 23 non-
O157 VTEC strains are part of the European Molecular 
Biology Laboratory’s European Nucleotide Archive Study 
(http://www.ebi.ac.uk/ena; accession no. PRJEB11886). 
The raw reads have been subjected to quality check through 
FastQC and trimmed with FASTQ positional and quality 
trimming tool to remove the adaptors and to accept 20 as 
the lowest Phred value (14).
We subjected the sequences obtained with the Ion 
Torrent apparatus to de novo assembly by using the tool 
SPADES (15) and those from Illumina by using the A5 
pipeline (16). The genomes have been assembled in several 
contigs ranging from 42 to 495 (mean 225), with N50 val-
ues (the length of the smallest contig among the set of the 
largest contigs that together cover at least 50% of the as-
sembly) between 40,736 and 347,638 (mean 152,953). All 
the contigs were uploaded to the EMBL European Nucleo-
tide Archive (accession no. PRJEB12203). We made anno-
tations by using the Prokka tool (17). All the bioinformatics 
tools used are available on the Aries public Galaxy server 
(https://w3.iss.it/site/aries/).
Virulence Gene Profile Analysis and Serotyping
The presence of vtx2f and eae genes has been assessed by 
PCR by using primers and conditions described elsewhere 
(5,18). The activity of VT2f has been evaluated by Vero 
cell assay (VCA) as previously described (19).
We performed detection of the virulence genes cif, 
efa1, espABCFIJP, etpD, iha, iss, katP, lpfa, nleABC, 
tccP, tir, toxB, ehxA, and espP and the serotype determi-
nation in silico on the WGSs. We used blastn (available 
on the Aries public Galaxy server at https://w3.iss.it/site/
aries/) to search databases containing the reference se-
quences of all the known virulence and serotype-associat-
ed genes of pathogenic E. coli (20). To perform the princi-
pal component analysis of the virulence gene profiles, we  
 
 
Table 1. Characteristics of non-O157 verotoxigenic Escherichia coli strains used in a comparative analysis of the virulence profile of 
VT2f-producing strains from humans and the animal reservoir* 
Strain Serogroup Source† Year of isolation Virulence gene profile  
ED017 O26 HUS 1989 eae vtx1 
ED075 O26 Diarrheal feces 1990 eae vtx1 
ED180 O26 HUS 1994 eae vtx2 
ED195 O26 HUS 1994 eae vtx1 
ED392 O26 Diarrheal feces 1998 eae vtx1 
ED411 O26 HUS 1999 eae vtx2 
ED423 O26 Diarrheal feces 1999 eae vtx1 
ED654 O26 HUS 2007 eae vtx2 
ED669 O26 HUS 2008 eae vtx1 
ED676 O26 HUS 2008 eae vtx2 
ED729 O26 Diarrheal feces 2010 eae vtx1 
ED766 O26 HUS 2010 eae vtx2 
ED657 O145 HUS 2007 eae vtx2 
ED603 O121 HUS 2004 eae vtx2 
ED073 O111 Diarrheal feces 1990 eae vtx1 
ED082 O111 HUS 1990 eae vtx1 
ED142 O111 HUS 1992 eae vtx1 vtx2 
ED178 O111 HUS 1994 eae vtx1 vtx2 
ED608 O111 HUS 2005 eae vtx1 vtx2 
ED664 O111 HUS 2007 eae vtx2 
ED672 O111 HUS 2008 eae vtx1 vtx2 
ED287 O103 Bovine 1998 eae vtx1 
ED728 O103 Bloody diarrheal feces 2010 vtx1 
*All samples are from humans except strain ED287. HUS, hemolytic uremic syndrome. 
†HUS samples were isolated from feces. 
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used SAS/IML studio software version 3.4 (SAS Institute, 
Inc., Cary, NC, USA).
We investigated plasmid profiles by using Plasmid-
Finder (21; https://cge.cbs.dtu.dk//services/all.php). The 
intimin subtyping has been performed in silico through a 
BLAST search (22) of the eae gene sequences from the 
WGS against the National Center for Biotechnology In-
formation nucleotide repository. The intimin types of the 
VT2f-producing strains isolated from pigeons have been 
published (6,10).
rpoB Sequencing and Analysis
Amplification and sequencing of the rpoB gene were con-
ducted to discriminate between E. coli and E. albertii spe-
cies, as previously described (23). The amplicons were 
purified with the SureClean Plus kit (Bioline, London, 
UK) and sequenced using the BigDye Terminator v1.1 
kit on a Genetic Analyzer 3130 (Thermo Fisher Scien-
tific). The obtained sequences were trimmed and aligned 
to the reference sequences as indicated (23), using the 
Clustal Omega free software (http://www.ebi.ac.uk/Tools/
msa/clustalo/).
Typing
We determined E. coli phylogenetic groups by using the 
method of Clermont et al. (24). We carried out multilo-
cus sequence typing (MLST) of the VT2f isolates in silico 
according to the scheme proposed by Wirth et al. (25). 
We analyzed the assembled sequences by using blastn to 
search the MLST database downloaded from the Internet 
site of the MLST.UCC Mark Achtman database (http://
mlst.warwick.ac.uk/mlst/dbs/Ecoli/).
Single-Nucleotide Polymorphism (SNP) Analysis
We analyzed SNPs by using the tool kSNP3 (26) available 
on the Galaxy project instance Aries (https://w3.iss.it/site/
aries/). We set a kmer value of 23.
Results
Characterization of the VT2f-Producing E. coli Strains
Serotyping
Of 11 VTEC strains isolated from humans with diarrhea, 5 
belonged to the O63:H6 serotype. The remaining 6 isolates 
contained the fliCH6 (3 strains), fliCH7 (1 strain), and fliCH34 
(2 strains) genes (Table 2) and belonged to serogroups O96, 
O113, O132, O145, and O125. For 1 isolate, the O-anti-
gen–associated genes could not be identified (Table 2) (12).
Molecular serotyping of the 8 VT2f-producing strains 
isolated from pigeons showed that all the isolates had the 
fliCH2 and the O4, O45, O75, and O128 serogroup-associ-
ated genes. The O-antigen genes could not be identified 
for the isolate ED 366 (Table 2). The HUS-associated  
 
 
Table 2. Characteristics of VT2f-producing Escherichia coli investigated in a comparative analysis of the virulence profile of strains 




isolated Serotype Phylotype MLST LEE adfO efa1 cif nleA nleB nleC Hly katP espP 
Intimin 
type 
Human diarrhea                
 M856 2008 ONT:H6 B2 ST583 + + – + – + + – – – -2 
 M858 2008 O125:H6 B2 ST583 + + – + – + – – – – -2 
 M859 2009 O113:H6 B2 ST121 + + – + – – – – – – -2 
 M884 2011 O96:H7 B2 ST28 + + – + + + – – – – -2 
 M885 2011 O132:H34 B2 ST582 + + – – – + + – – – -2 
 M900 2012 O145:H34 B2 ST722 + + – – – + – – – –  
 BCW5711 2012 O63:H6 B2 ST583 + + – + + – + – – – -2 
 BCW5746 2012 O63:H6 B2 ST583 + + – + – – + – – – -2 
 BCW5743 2012 O63:H6 B2 ST583 + + – + – – + – – – -2 
 BCW5739 2012 O63:H6 B2 ST583 + + – + – – + – – – -2 
 BCW5717 2012 O63:H6 B2 ST583 + + – + – – + – – – -2 
Pigeon                
 ED360 1997 O45:H2 B1 ST20 + + – + + + + – – – β 
 ED361 1997 O75:H2 B1 ST20 + + – + + + + – – – β 
 ED363 1997 O4:H2 B1 UNK + + – + + + + – – – β 
 ED366 1997 ONT:H2 B1 ST2685 + + – + + + + – – – β 
 ED369 1997 O45:H2 B1 ST20 + + – + + + + – – – β 
 ED377 1997 O4:H2 B1 UNK + + – + + + + – – – β 
 ED430 2000 O45:H2 B1 ST20 + + – + + + + – – – β 
 ED444 2000 O128:H2 B1 ST20 + + – + + + + – – – β 
HUS                
 EF453 2013 O80:H2 B1 ST301 + + + – + + + + – +  
 EF467 2013 O26:H11 B1 ST21 + + + + + + + + + +  
 EF476 2014 O55:H9 B1 ST301 + + + – + + + + – + ξ 
*Human samples were diarrheal or fecal samples from HUS cases and pigeon samples were feces from asymptomatic birds. LEE, locus of enterocyte 
effacement; MLST, multilocus sequence type; UNK, unknown; +, positive; –, negative. 
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VT2f-producing E. coli strains EF453 and EF476 be-
longed to serotypes O80:H2 and O55:H9, respectively, 
while strain EF467 was O26:H11.
Virulence Gene Profiles
The E. coli strains carrying the vtx2f and isolated from pi-
geons have been previously reported to produce an active 
VT2f (6). As expected, culture supernatants from VT2f-
producing strains isolated from human diarrhea and HUS 
induced a cytopathic effect on Vero cells morphologically 
compatible with that caused by verocytoxins.
All the VT2f-producing strains included in the study 
were positive for the eae gene (Table 2) and displayed 
the presence of the entire locus of enterocyte effacement 
(LEE) (data not shown). Most of the E. coli VT2f-pro-
ducing strains isolated from diarrheal cases harbored the 
α-2 intimin type (8/11), followed by the β-2 (2/11) and ι 
(1/11) types. The VT2f-strains isolated from pigeons had 
been previously described to have the β-intimin (6) in 
most cases and, more rarely, the α-2 intimin type (10). Of 
3 HUS-associated VT2f-producing strains, 2 (EF453 and 
EF476) carried the ξ intimin type and 1 (EF467) had the 
β intimin (Table 2).
All the pigeon and HUS isolates possessed the com-
plete set of non–LEE-encoded effectors assayed (nleA, 
nleB and nleC) (27), whereas the isolates from human diar-
rhea cases displayed an unequal presence of these genes 
(Table 2). The efa1 gene, hallmark of the OI-122 patho-
genicity island (28), was not identified in the isolates from 
pigeons or from human diarrheal specimens; neither were 
the genes ehxA, espP and katP, usually present on the large 
virulence plasmid of VTEC O157 and other VTEC associ-
ated with severe human disease (Table 2). However, the 
gene adfO, present on the OI-57 (29), was detected in all 
the strains investigated (Table 2).
The HUS strains EF453, EF467, and EF476 had the 
entire efa1 gene. Strain EF467 also had the ehxA, espP, 
and katP genes; the EF453 and EF476 strains had the 
ehxA and espP genes only (Table 2). The analysis of 
the plasmid profiles substantiated the finding that the 3 
HUS-associated strains carried the large virulence plas-
mid of VTEC, revealing the presence of a sequence 100% 
homologous to the replicon sequence of the pO26-CRL 
plasmid from a VTEC O26:H- (GenBank accession no. 
GQ259888.1), which harbors the genes ehxA, espP, 
and katP.
On the basis of plasmid profiles analysis, 7 of 11 E. 
coli VT2f-producing strains isolated from human diarrheal 
feces seemed to have the replicon sequence of the plasmid 
pSFO (GenBank accession no. AF401292) encoding the 
enterohemolysin and a cluster of pap-like genes called sfp 
in a sorbitol-fermenting E. coli O157 (30). However, the 
analysis of the WGSs failed to identify the ehxA and the 
pap-like sequences, suggesting that the entire pSFO plas-
mid was not present.
Principal component analysis of the virulence genes 
profiles showed that the HUS isolates producing VT2f 
clustered with the set of non-O157 VTEC isolates used 
for comparison, rather than with the other VT2f-producing 
strains (Figure 1). Conversely, the VT2f-producing strains 
from diarrhea and from pigeons grouped together and apart 
from the HUS strains (Figure 1).
Phylogenetic Analyses
rpoB Analysis
All the VT2f-producing isolates had an E. coli-related rpoB 
sequence (23). This finding verified that all the strains in-
vestigated were E. coli.
Typing
All VT2f-producing E. coli isolates from pigeons and the 
strains isolated from HUS belonged to the B1 phylogenetic 
group. All the strains isolated from human diarrheal feces 
were of phylotype B2 (Table 2).
By MLST, most of the pigeon strains investigated 
(5/8) belonged to sequence type (ST) 20; 1 was ST2685, 
and 2 were of unknown ST (Table 2), mainly because of 
the absence of a recognizable adk gene sequence. The 5 
O63:H6, the 1 O125:H6, and the 1 ONT:H6 VTEC strains 
from diarrheal fecal specimens belonged to ST583; of the 
remaining 4 strains, 1 each was of sequence types ST28, 
ST121, ST582, and ST722 (Table 2).
Of 3 HUS-associated VT2f-producing E. coli, 2 
(EF453 and EF476) belonged to ST301; strain EF467 
was of ST21 (Table 2). All of the STs belonged to dif-
ferent clonal complexes or to any clonal complex, in-
dicating that they were not related each other (data 
not shown).
SNP Analysis
A parsimony tree representing the core-genome SNPs 
analysis (Figure 2) shows that VT2f-producing strains 
from pigeons, human diarrheal feces, and HUS cases clus-
ter apart from each other and from other VTEC strains used 
for comparison. The HUS-associated EF467 strain clusters 
together with the group of VTEC non-O157 from human 
disease, in agreement with the principal component analy-
sis (Figures 1, 2).
Identification of a Bacteriophage Containing  
the vtx2f Genes
The contigs containing the vtx2f genes in the different 
strains ranged 2,500–68,480 bp in size. Upon annota-
tion, they showed the presence of phage-associated genes 
in the proximity of vtx2f, including those encoding the 
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antitermination protein Q, the lysis protein S, a phage ter-
minase, an integrase, and tail-assembly proteins.
We used WGS of HUS strain EF467 to assemble 
a partial VT2f phage sequence of 38,594 bp (online 
Technical Appendix, http://wwwnc.cdc.gov/EID/
article/22/12/16-0017-Techapp1.pdf). Analysis of the 
construct highlighted the absence of most of the genes 
normally involved in the regulation of the switch be-
tween the lysogenic state and the lytic cycle of lambdoid 
phages, such as cro, cI, cII, cIII, and N. We confirmed 
these findings by mapping the raw reads of the WGS 
of the strain EF467 against the VT2 reference bacte-
riophage BP933W (GenBank accession no. AF125520) 
(not shown).
We confirmed the genomic structure of VT2f phage 
obtained in silico by 4 PCRs performed on the total DNA 
extracted from strain EF467 by using primer pairs designed 
on the construct’s map and by using a restriction fragment 
length polymorphism analysis on the obtained PCR frag-
ments (Table 3; online Technical Appendix). The partial 
VT2f phage sequence was deposited into the EMBL data-
base (accession no. LN997803).
The portion of the VT2f phage spanning the xerC gene 
and the tRNA-Gly and tRNA-Thr loci (online Technical 
Appendix) was found in the draft genomes of all the VT2f-
producing strains. The region downstream to the tRNA loci 
was also detected, but with different degrees of variation 
among the WGSs; for example, the presence of an addi-
tional DNA stretch of ≈24 kb in the strain BCW5746 (on-
line Technical Appendix).
The presence of a similar phage structure was con-
firmed by using a long PCR approach in the other 2 VT2f-
producing E. coli from HUS cases and in 2 strains from 
pigeons (strains ED377 and ED363). All the strains showed 
the expected amplicons with PCR 2 and 3 together with 
the expected product of PCR 1 in 2 pigeon isolates; all the 
isolates tested did not yield any amplicon with PCR 4 (Fig-
ure 3). A comparative analysis of the xerC sequences from 
all the VT2f phage constructs returned a high degree of 
variation in its sequence, explaining the observed absence 
of the PCR4-specific amplicon (data not shown). Finally, 
a BLAST search by using this VT2f phage construct from 
strain EF467 returned only partial similarity with phages 
identified in different Enterobacteriaceae but did not re-
trieve similar structures.
Discussion
VTEC producing the VT2f subtype have long been con-
sidered a minor public health problem because of their 
rare association with human infections (31–34). Recently, 
however, an increasing number of reports of human dis-
eases caused by infection with these E. coli strains have 
Figure 1. Principal component 
analysis of the virulence profiles 
of VT2f-producing verotoxigenic 
Escherichia coli (VTEC) strains 
isolated from fecal samples from 
human uncomplicated diarrheal 
case-patients (orange), human 
hemolytic uremic syndrome 
patients (red), and pigeon 
feces (green). Non-O157 
VTEC that do not produce 
VT2f are indicated in purple. 
This analysis clusters isolates 
on the basis of similarities in 
virulence gene content. Isolates 
clustering together have 
similar virulence profiles. Lines 
represent individual virulence 
genes. The projected length 
of the lines on the horizontal 
and vertical axes indicates the 
strength of the contribution of 
a specific virulence marker to 
the separation of clusters. Dim1 
and Dim2 represent the first 
2 dimensions of the analysis 
and indicate the fraction of 
variation in the dataset that can 
be explained by the included 
variables (i.e., virulence genes).
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populated the literature (11,12,32,35). The diversity of 
vtx2f gene sequences compared with other vtx2 subtype 
genes may have played a role in underestimating the global 
burden of such infections. PCR primers mostly used for 
the detection of vtx2 genes in clinical specimens and the 
vehicles of infection have been proven to be unable to am-
plify the vtx2f gene (36). In addition, the recent description 
of another eae-positive Escherichia species often isolated 
from birds, and sometimes carrying vtx2f genes, E. alber-
tii, added a further element of confusion. E. albertii has 
been associated both with gastroenteritis in humans and 
with healthy and diseased birds (37,38), but this species is 
difficult to distinguish from E. coli when using the usual 
biochemical or molecular assays.
Most human infections with VTEC producing VT2f 
have been reported as uncomplicated diarrheal cases 
(11,12), which may also have accounted for the under-
estimation of these infections. Because such cases are 
not actively surveyed in many countries, these infections 
may have been overlooked. The recent description of an 
HUS case associated with a VT2f-producing E. coli (13) 
changed the perspective on VT2f-producing E. coli and the 
associated disease, making it necessary to update the cur-
rent paradigm of HUS-associated VTEC.
Figure 2. Parsimony tree obtained from the 
core-genome single-nucleotide polymorphism 
analysis of VT2f-producing verotoxigenic 
Escherichia coli (VTEC) strains from this study 
compared with VTEC belonging to the most 
relevant serogroups with publicly available 
sequences. In detail: 2 VTEC O157:H7 strains, 
EDL933 and Sakai (GenBank accession nos. 
NZ_CP008957.1 and NC_002695.1); 1 O26:H6, 
strain 11368 (accession no. NC_013361.1); 
1 O145:H28, strain RM12581 (accession no. 
NZ_CP007136.1); and 1 O111:H-, strain 11128 
(accession no. NC_013364.1). Scale bar 




Table 3. PCR and restriction fragment length polymorphism analysis conditions used to verify VT2f phage structure in a comparative 
analysis of the virulence profile of human and zoonotic VT2f-producing Escherichia coli strains* 
Analysis 





bp + bp) 
PCR1 φ-vtx2f_1FW caccatatcccagcaactgc  1,985–2,005 95°C for 2 min, 30 (94°C 
for 30 s, 53°C for 30 s, 70°C 
for 9 min); 72°C for 10 min 
6,331 PvuI (1,773 + 4,558)  
φ -vtx2f_1RV gttggcggttccgactacaa 8,315–8,296 
PCR2 φ -vtx2f_2FW gcgcatcaccacttcatctt  8,337–8,357 95°C for 2 min, 30 (94°C 
for 30 s, 53°C for 30 s, 70°C 
for 9 min), 72°C for 10 min 
8,166 HindIII (1,855 + 
6,311) 
 
128–1 agattgggcgtcattcactggttg 16,502–16,479 
PCR3 φ -vtx2f_3FW ggagtggatattgccgacct 16,808–16,827 95°C for 2 min, 30 (94°C 
for 30 s, 53°C for 30s, 70°C 
for 9 min), 72°C for 10 min 
3,927 BgIII (1,310 + 2,617)  
φ -vtx2f_3RV gtcttcctgctgaggcgatc 20,734–20,715 
PCR4 φ -vtx2f_4FW taatcgcggccgtactcaag 22,172–22,191 95°C for 2 min, 30 (94°C 
for 30 s, 53°C for 30 s, 70°C 
for 9 min), 72°C for 10 min 
8,808 NcoI (5,029 + 3,779)  
φ -vtx2f_4RV tgttcagctccaccttacgg 30,979–30,960 
*Analysis for PCR2, primer 128–1 from (5); all other data were compiled for this study. All the long PCR described were performed with the GoTaq Long 
PCR Master Mix (Promega, Madison, WI, USA) according to manufacturer’s instructions. Primer positions refer to the phage sequence deposited into the 
EMBL database (accession no. LN997803). 
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We provide evidence that the VT2f-producing E. coli 
isolated from HUS cases display the complete set of viru-
lence genes described in the typical HUS-associated VTEC 
(Table 2; Figure 1) (28). All VT2f strains from HUS that 
we examined were positive for pathogenicity island OI-
122 (28) and the large virulence plasmid first described in 
VTEC O157 (Table 2) (39); the strains from pigeons or 
from humans with uncomplicated diarrhea did not have 
these virulence-associated mobile genetic elements (Table 
2) (10–12,32,40).
Our study also showed that the LEE was complete in 
all the genomes investigated, but a complete set of nleABC 
genes was found only in strains from pigeons and from 
humans with HUS (Table 2), indicating that the VT2f-
producing isolates investigated belonged to 3 distinct main 
virulotypes or subpopulations (Table 2). The intimin sub-
typing supported this observation. Of 11 diarrheal isolates, 
8 had the α-2 gene; all the pigeon isolates had a β intimin 
coding gene. Finally, 2 of the 3 strains from HUS showed 
the presence of a gene encoding the ξ intimin (Table 2). 
Furthermore, the analysis of core genome SNPs confirmed 
the existence of different subpopulations of VT2f-produc-
ing E. coli (Figure 2). The analysis of the virulence genes 
suggests that different populations of VT2f-producing E. 
coli exist and have different potential to cause human dis-
ease on the basis of the virulotype to which they belong.
VT2f-producing E. coli strains isolated from uncom-
plicated human cases of diarrhea have been reported in the 
literature as being ST20 (11), which is the same sequence 
type we identified in most pigeon isolates; this ST was 
also described in VT2f-producing E. coli isolated from 
pigeons in Japan (40). The same study also described an 
animal isolate of ST722, which was found in 1 strain iso-
lated from human diarrheal feces in our study (Table 2). 
Similarly, the serotypes in some cases appeared to overlap 
isolates from pigeons and human cases of diarrhea, such 
as the serotype O128:H2 that we found in 1 pigeon isolate 
that was also reported in isolates from human cases of 
diarrhea in Germany (11).
Altogether, these observations indicate that the VT2f-
producing E. coli causing diarrhea in humans could be a 
subpopulation of those inhabiting the pigeon reservoir. Al-
ternately, information on the serotypes, ST, and principal 
component analysis of virulence genes profiles supports the 
hypothesis that the HUS VT2f-producing strains are more 
similar to the non-O157 VTEC often isolated from samples 
from humans with severe disease (Figure 1) than to the oth-
er VT2f-producing E. coli from humans with diarrhea or 
from asymptomatic pigeons. This hypothesis suggests that 
the HUS VT2f-producing strains represent a distinct popu-
lation of VTEC; whether they are part of the pigeon intes-
tinal flora or arise from an acquisition of the vtx2-phage is 
difficult to ascertain. 
The phylogeny of VTEC of different serogroups, in-
vestigated by core SNP analysis, showed that the different 
VT2f-producing E. coli cluster into different subpopula-
tions that include strain EF467 grouping together with non-
O157 VTEC strains from humans with disease (Figure 2). 
However, the results from SNP analysis for VTEC of mul-
tiple serogroups should be carefully evaluated; the popula-
tion structure of VTEC belonging to serogroups other than 
O157 and O26 has not been completely investigated yet.
At the first characterization of the vtx2f genes, it was 
proposed that they were, similar to other VT-coding genes, 
located on bacteriophages (5). Our study confirms this hy-
pothesis and shows that such a phage apparently does not 
have similar counterparts in the VT-phage genomes re-
ported in the National Center for Biotechnology Informa-
tion nucleotide repository (http://www.ncbi.nlm.nih.gov/). 
In addition, we observed that VT2f phage was very similar 
Figure 3. Long PCR analysis of the VT2f phage of verotoxigenic Escherichia coli (VTEC) strains isolated from fecal samples from 
humans with hemolytic uremic syndrome (EF467, EF476, EF453) and from pigeon feces (ED363, ED377). Numbers at left indicate bps; 
lane numbers indicate PCR 1 to PCR 4. The expected size of the amplicons were 6,331 bp (PCR 1), 8,166 bp (PCR 2), 3,927 bp (PCR 
3), and 8,808 bp (PCR 4).
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in all the VT2f-producing E. coli investigated (Figure 3; on-
line Technical Appendix), suggesting that the vtx2f genes 
are present in phages sharing a common ancestor that is dif-
ferent from other phages with the other vtx1/vtx2 subtypes.
In conclusion, we provide evidence that human infec-
tions with VT2f-producing E. coli are zoonotic diseases 
transmitted from pigeons. Such an animal reservoir may ei-
ther directly disseminate VTEC strains causing diarrhea or 
indirectly release VT2f phages in the environment, which 
can in turn lysogenize E. coli strains that contain acces-
sory virulence determinants and confer them the ability to 
cause HUS. The isolation of VT2f-producing E. coli with a 
virulence gene profile related to the other HUS-associated 
VTEC suggests that the severity of the symptoms induced 
by infection may depend more on the ability to achieve a 
proficient colonization of the host gut mucosa rather than 
on the subtype of the produced toxin.
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Foodborne illness (sometimes called “food-
borne disease,” “foodborne infection,” or 
“food poisoning”) is a common, costly—yet 
preventable—public health problem. Each 
year, 1 in 6 Americans gets sick by consum-
ing contaminated foods or beverages. Many 
different disease-causing microbes, or 
pathogens, can contaminate foods, so there 
are many different foodborne infections. 
In addition, poisonous chemicals, or other 
harmful substances can cause foodborne 
diseases if they are present in food.
®
